Molecular Classification Substitutes for the Prognostic Variables Stage, Age, and MYCN Status in Neuroblastoma Risk Assessment-Reference-Cited by-同舟云学术

Molecular Classification Substitutes for the Prognostic Variables Stage, Age, and MYCN Status in Neuroblastoma Risk Assessment

Published:2017-12 Issue:12 Volume:19 Page:982-990
ISSN:1476-5586
Container-title:Neoplasia
language:en
Short-container-title:Neoplasia

Author:

Rosswog Carolina,Schmidt Rene,Oberthuer André,Juraeva Dilafruz,Brors Benedikt,Engesser Anne,Kahlert Yvonne,Volland Ruth,Bartenhagen Christoph,Simon Thorsten,Berthold Frank,Hero Barbara,Faldum Andreas,Fischer Matthias

Funder

German Ministry of Science and Education

Fördergesellschaft Kinderkrebs-Neuroblastom-Forschung e.V.

Center for Molecular Medicine Cologne

Publisher

Elsevier BV

Subject

Cancer Research

Reference42 articles.

1. Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterations;Bosse;Cancer,2016

2. Recent advances in neuroblastoma;Maris;N Engl J Med,2010

3. Mechanisms of neuroblastoma regression;Brodeur;Nat Rev Clin Oncol,2014

4. Localized infant neuroblastomas often show spontaneous regression: results of the prospective trials NB95-S and NB97;Hero;J Clin Oncol,2008

5. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment;Brodeur;J Clin Oncol,1993

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of MYCN non-amplified neuroblastoma subgroups points towards molecular signatures for precision prognosis and therapy stratification;British Journal of Cancer;2024-03-29

2. PPARβ/δ-ANGPTL4 axis mediates the promotion of mono-2-ethylhexyl phthalic acid on MYCN-amplified neuroblastoma development;Science of The Total Environment;2024-02

3. Molecular Subtypes of Amino Acid Metabolism-Related Genes Predicting Prognosis, Tumor Microenvironment Composition, and Therapeutic Response in Neuroblastoma;2024

4. Identification of a novel gene signature for neuroblastoma differentiation using a Boolean implication network;Genes, Chromosomes and Cancer;2023-02-13

5. Comparative epigenomics by machine learning approach for neuroblastoma;BMC Genomics;2022-12-27